Brazil Hepatitis C Drug Market Analysis


  • Type: Common Disease Area
  • Published : May 2021
  • Region: LATAM
  • Country: Brazil
  • Report ID : 4617

  • Format: PPT, PDF

Brazil Hepatitis C Drug Market – Segmented by Product Type (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, and Others) by Disease Type (Acute and Chronic Hepatitis C) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The Brazil Hepatitis C Drug Market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Hepatitis C is a viral infection primarily affecting the liver, it often leads to cirrhosis and further cirrhosis may develop complications such as liver failure, liver cancer, or oesophageal and gastric varices. The prevalence of this disease is because in early stage of infection, typically it has no symptoms. Critical stage of infection may display symptoms such as fever, dark urine, abdominal pain, and yellow tinged skin occurrence. People with alcoholism and HIV infection of any age group are at increased risk.

Currently, Hepatitis C is a key challenge to public health in Brazil and even WHO is helping the government to drive out this issue.

Market Growth Drivers

The market for hepatitis C is driven by factors such as increase in disease prevalence caused by sharing needles, unsterilized medical equipment, blood transfusion from person, drug abuse and unsafe sex etc

Other prominent factors are- rise in government subsidy and reimbursement by SUS and higher investment in pipeline studies by big players of the market.

Market Restraints

High cost of drugs is the top restraint for the market, as it makes the treatment cost much higher and the general population cannot afford it. Exclusivity of American laboratory in the sale of hepatitis C medicine prevents national manufacture and raises price in Brazil.

Due to better screening, drugs are not easily approved in the market, affecting the availability of products in the market and self-imitating nature of the disease in a sizable number of patients are some other primary restraints in the market.

1. Brazil Hepatitis C Drug Market Overview…….…………….………………
A. Market Size
2. Market Growth Drivers……………………………………………………………………….
A. Increase in disease prevalence
B. Better government policies
C. Higher investment in pipeline studies
3. Market Restraints……………………………….……….……………….………………..
A. High cost of drugs
B. Availability of products in the market
C. Self-imitating nature of the disease
4. Hepatitis C Drug Market Segmentation….…………………….……
A. By Product Type
I. NS5A Inhibitor (Protease Inhibitors)
II. Fixed-dose Combination
III. Others
B. By Disease Type
I. Acute Hepatitis C
II. Chronic Hepatitis C.
C. By Distribution Channel
I. Hospital pharmacies
II. Retail pharmacies
III. Online pharmacies
IV. Others
5. Hepatitis C Drug Market Share………….…………….………..…….
A. Market Analysis, Insights and Forecast
6. Competitive Landscape…………………………….……………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………….……………………………………….………………..
A. Abbvie Inc. Company, Product & Services, Strategies & Financials
B. Gilead Sciences Inc. Company, Product & Services, Strategies & Financials
C. Blanver Pharmaceuticals Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………….…….……….….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development in Hepatitis C Drug Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Product Type:

On the basis of product type, the market is be segmented into NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, and Others. The Fixed-dose Combination segment is holding the dominant share and is estimated the highest CAGR due to effectiveness across all the genotypes of Hepatitis C and the recent product launches and presence of major drugs in this segment.

By Disease type:

On the basis of disease type, the market is be segmented into acute and Chronic Hepatitis C. The chronic Hepatitis C segment is anticipated to grow at a faster CAGR, primarily because 75%-85% of all the cases of acute Hepatitis C develop into the chronic form because of limited number of symptom and low detection rates in initial stages.

By Distribution Channel:

On the basis of the distribution channel, the market is be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment is controlling the dominant share because these institutions ensure a greater deal of safety and greater guidance regarding the administration of therapeutics. Also subsidised rates at hospital and government care programs are boosting their market share.

Major Players

Key players of the in the hepatitis C treatment market include AbbVie Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Johnson & Johnson, etc.

The company with major market share is Gilead Sciences Inc., which contributes majorly by investing highly in the pipeline studies as well as works in collaboration with government and providing negotiated import prices in the country. Gilead’s major competitor in this segment is Blanver pharmaceuticals, which is responsible for developing generic medicines in the country.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements